●
Earnings Feed
Filings
Companies
Insiders
Pricing
Blog
⌘
K
Login
Start Free
$SLN
·
10-K
Silence Therapeutics plc · Mar 5, 7:49 AM ET
Share
Compare
Silence Therapeutics plc 10-K
Loading document...
Share
More
Contents
2
6. Restructuring charges
During the twelve months ended December 30, 2025, the Group initiated a non-recurring reduction in workforce which resulted in total restructuring charges of $1.3 million. The charges consist of severance costs for terminated employees. The remaining accrual at December 31, 2025 was $0.1 million.
Contents
Share
More
Download PDF